Thrilled to have just arrived at expopharm in Munich! Looking forward to the next two days of innovation, networking, and exploring the latest in the pharmaceutical industry. #expopharm #germany #munich expopharm
Canexis Pharma AG’s Post
More Relevant Posts
-
✨ Today’s Pharma Daily Digest delivers critical insights that are reshaping the future of #metabolics and #cardiovascular treatments. Here’s a glance at the biggest developments that you need to know. 🚀 Novo Nordisk’s #Wegovy poised for 2025 regulatory approval after promising phase III #MASH trial, outperforming Madrigal Pharmaceuticals' #Rezdiffra in #Liver #Fibrosis and targeting broader #cardiovascular benefits 🔻 Lexicon Pharmaceuticals, Inc. faces setback as FDA Advisory Committee rejects #Zynquista for Type 1 #diabetes, marks the end of $260M partnership with Sanofi. The FDA Advisory Committee voted 11-3 against the approval of Zynquista, raising concerns that could impact the drug’s path to market and future potential. ----- 💡 Sign up for our Daily Digest to stay updated on the pharma and biotech advancements shaping tomorrow’s healthcare breakthroughs. Don’t miss the insights that could impact your next strategic move! #PharmaDailyDigest #Pharmaceuticals #Biotech #CompetitiveIntelligence #AtacanaGroup #novonordisk #Sanofi #Lexicon #madrigal
-
Autoinjectors Market Size to reach USD 1.7 billion procedures by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬: https://lnkd.in/d-vDXXym The global autoinjectors market in terms of revenue was estimated to be worth $0.9 billion in 2023 and is poised to reach $1.7 billion by 2028, growing at a CAGR of 14.0% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Becton, Dickinson and Company Ypsomed Holding AG SHL Medical West Pharmaceutical Services Recipharm Haselmeier GmbH Owen Mumford Gerresheimer Phillips Medisize Oval Medical Technologies Ltd Kaléo Solteam Incorporation. E3D Elcam Drug Delivery Devices Crossject Johnson & Johnson MedTech Antares Pharma Inc. Jabil Congruence Medical Solutions AbbVie Amgen Eli Lilly and Company Novartis Merck KGaA, Darmstadt, Germany Viatris Biogen
-
-
In-depth discussions on the strategic formation of partnerships between AI drug discovery companies and pharmaceutical firms, beginning as early as the IND stage. These collaborations are designed to preserve the AI-driven benefits of the drug discovery company while enabling pharmaceutical companies to utilize their clinical trial expertise. A practical example of this approach is showcased by the industry leader, Insilico Medicine. This session is poised to be one of the year's highlights in AI drug discovery. #bioconvention #InsilicoMedicine #AIdrugdisovery
-
-
Let me know if you need additional information on innovative formulation utilizing MMC!
Redeye congratulates Disruptive Pharma AB (publ) on the successful outcome of the company's capital raise of SEK 26.7 million, in which Redeye acted as Financial Advisors. Disruptive Pharma is a pharmaceutical company utilizing its innovative MMC drug delivery technology to enable amorphous drug formulations. We aim to collaborate with partners to transform their APIs into new and commercially attractive drug products. Disruptive Pharma provides MMC technology and expertise to address drug delivery challenges. The company's MMC technology is based on particulate amorphous mesoporous magnesium carbonate, providing competitive advantages over other technologies. Additionally, the company is developing its own pipeline of supergeneric/505(b)(2) products to address significant unmet medical and commercial needs. Its flagship product, an MMC-enhanced sorafenib for the treatment of HCC and RCC, will enter clinical trials in the second half of 2024.
-
-
A great look into the world of pharma through the eyes of the incredible Samuel Hollis. It’s a must read for those of you who are interested in making the move into pharma, or simply want to learn more about the industry! 🗞️💊
💊 Samuel Hollis takes us on his two-decade journey through the pharmaceutical industry, sharing insights from his roles across the UK, Switzerland, and the US. Samuel talks about his passion for science, career progression, and the importance of innovation and leadership in pharma. This edition provides some valuable insight into the pharmaceutical industry, including what it takes for clinicians to make the switch into pharma. He also delves into his fascinating lobster theory! Make sure you give the article a read on Peerr to find out more ⬇🦞 https://lnkd.in/eQ_h_Mec
-
-
The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2024 welcomes heads of pharmaceutical companies to exchange ideas about innovative labels and packaging solutions. In that case, the company Themis Medicare Limited participates at the session discussion with a topic about high demand of AI, automation and digitalisation in pharma packaging. Together with the speakers from Bayer | Pharmaceuticals, LETI Pharma , Lucerne University of Applied Sciences and Arts, SCHOTT Pharma and Schreiner MediPharm, experts are discussing: ● Challenges in labelling automation for individualised medicines; ● Automation in the delivery of electronic product information; ● How medicine packaging enhance healthcare; ● Enhancing primary containers through smart RFID-Labels. Register as a speaker to share your thoughts: https://sh.bgs.group/21n #AUTOMAplus2024 #pharmaceutical #automation #digitalisation #BGSGroup #businessworld #digitalnews #globalnews #news #onlinenews #events #internationalnews #businessleaders #newsupdates #newsoftheday #businessbuilding #latestnews #subscribe #follow #businessfocus
-
-
Senior Market Development Manager Pharma/CRO (MS & CE) & Aftermarket EMEAI at SCIEX
WEBINAR ALERT: PHARMA CONCLAVE SERIES 2024. NITROSAMINE ANALYSIS Nitrosamines and NDSRIs are still one of the hottest topics in the pharma industry. Join this webinar on the next 17th of September starting at 10 AM CET and listen how 2 of the leaders on this field have been working during the last years to understand the difficulties and find solutions for producing safe drugs. Thanks to Dev Kant Shandilya, PhD, MBA from FRESENIUS KABI ONCOLOGY PLC (Fresenius Kabi) and Dr. Harsha Narasimhaiah from Recipharm to share their knowledge and expertise. #pharmaindustry #pharma #drugproduction #drugdevelopment #smallmolecules #qualitycontrol #nitrosamines #ndsri #genotoxic #webinar
Join us at Pharma Conclave 2024 series Session 2: Impurities in the Pharmaceutical Industry. What's Next? Register Here: https://sciex.li/qzsv4x Speakers: Dev Kant Shandilya, PhD, MBA - Fresenius Kabi Oncology Limited Dr. Harsha Narasimhaiah - Recipharm Pharma Services Pvt Ltd Don't miss out on this opportunity to enhance your expertise and engage with thought leaders in the pharmaceutical field. Click the link to register now! #PharmaIndustry #Pharmaceuticals #Impurities #PharmaSession #Networking #IndustryExperts #SCIEX Nando (Ferran) Sánchez Manoj Pillai Pankaj Partani Anoop Kumar Ph.D Nidhi Aggarwal Babla Pendam Parakh Sachdeva Ranjith Kumar Ponnamaneni
-
-
I’m happy to announce that my review article titled “Artificial Intelligence in Drug Discovery and Drug Designing” has been published in the International Journal of Pharmaceutical Research and Applications (IJPRA)! International Journal of Pharmaceutical Research and Applications (IJPRA) In this article, I explore how AI is transforming the pharmaceutical industry by enhancing drug discovery processes and accelerating drug design with greater precision. The integration of AI into healthcare has immense potential to revolutionize treatment strategies and bring new therapies to patients faster than ever before. 🚀💊 Feel free to check out the publication here: https://lnkd.in/dvz2t_cE #ArtificialIntelligence #DrugDiscovery #PharmaceuticalResearch #DrugDesigning #IJPRA #Research #AI #Healthcare #Pharmacy
-
-
Sanofi collaborates with OpenAI to pioneer AI-driven pharmaceuticals #innovation 🤝 Download 1 Million Logo Prompt Generator 🔜 https://wapia.in/1mlogo 🤝 Follow us on Whatsapp 🔜 https://wapia.in/wabeta _ ❇️ Summary: Sanofi has partnered with OpenAI to leverage artificial intelligence in becoming the first AI-driven pharmaceutical company in the world. This collaboration aims to enhance drug discovery and development processes by utilizing advanced AI technology. By incorporating AI into their operations, Sanofi aims to improve efficiency, accelerate innovation, and ultimately deliver better healthcare solutions to patients. This partnership signifies a significant step towards revolutionizing the pharmaceutical industry through the integration of cutting-edge technology. Hashtags: #chatGPT #AIpharma #SanofiOpenAI
-
Read Now: https://lnkd.in/gR5XTrKc Incorporating AI in pharmaceutical operations is essential for staying competitive. Abid Rahman, SVP of Innovation at EVERSANA, explains how AI is revolutionizing across pharma. Dive into his Q&A on Pharmaceutical Executive. #AI #PharmaTech #EVERSANA
-
